Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Aziyo Biologics Q2 EPS $(0.65) Misses $(0.29) Estimate, Sales $10.30M Miss $12.50M Estimate

Author: Benzinga Newsdesk | August 14, 2023 04:41pm
Aziyo Biologics (NASDAQ:AZYO) reported quarterly losses of $(0.65) per share which missed the analyst consensus estimate of $(0.29) by 124.14 percent. This is a 5.8 percent increase over losses of $(0.69) per share from the same period last year. The company reported quarterly sales of $10.30 million which missed the analyst consensus estimate of $12.50 million by 17.63 percent. This is a 18.53 percent decrease over sales of $12.64 million the same period last year.

Posted In: AZYO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist